NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs041180050

Registered date:20/02/2019

Exposure Frequency of Allergen in oral ImmunoTherapy

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedFood allergy
Date of first enrollment06/06/2017
Target sample size40
Countries of recruitment
Study typeInterventional
Intervention(s)the participants in frequent group intake the allergic food daily in low dose oral immunotherapy. the participants in intermittent group intake the allergic food twice weekly in low dose oral immunotherapy.

Outcome(s)

Primary OutcomeDifference of amount of intake in oral food challenge after 12 +- 2 months from start of low dose oral immunotherapy between frequent (daily intake) group and intermittent (twice weekly intake) group.
Secondary OutcomePrimary outcome which divided into subgroup of egg allergy and milk allergy. Difference of Egg white and ovomucoid-sIgE or milk and casein-sIgE after 12 +- 2 months from start the OIT between the frequent and the intermittent groups, which divided into the egg and the milk subgroups. Difference of Egg white and ovomucoid-sIgE or milk and cazein-sIgG4 after 12 +- 2 months from start the OIT between the frequent and the intermittent groups, which divided into the egg and the milk subgroups. Difference of increasing rate of amount of intake in oral food challenge from before the OIT to after the OIT between the frequent group and the intermittent group. Difference of increasing rate of ovomucoid-sIgE in egg allergy and milk-sIgE in milk allergy from before the OIT to after the OIT between the frequent group and the intermittent group. Difference of the FAQ after 12 +- 2 months from start of the OIT between the frequent group and the intermittent group. Difference of the VAS scale for degree of difficulty of intake the foods after 12 +- 2 months from start of the OIT between the frequent group and the intermittent group.

Key inclusion & exclusion criteria

Age minimum>= 6month old
Age maximum< 6age old
GenderBoth
Include criteriaChildren aged 6 months or older, 6 years or younger Children who were diagnosed with a positive by open oral food challenge (OFC) with boiled egg white / milk, which total dose of 1-10 g. Excluding positive only for the symptoms around the oral cavity. Children who can be Track one year and track confirmation OFC one year later. A person who consented to the study by a substitute person who is a parental author in writing.
Exclude criteriaChildren already doing oral immunotherapy for the relevant foods, including irregular processed goods. Children who intake the other allergic food for oral immunotherapy within 2 hours of food intake for this trial. Those with poor control of atopic dermatitis and bronchial asthma. Children with chronic urticaria. Children who is planning to move within 1 year. The cases who have serious complications and doctor determines that it is inappropriate for this study

Related Information

Contact

Public contact
Name Osamu Natsume
Address 1-20-1 Handayama,Higashi-ku,Hamamatsu,Shizuoka,Japan, Shizuoka Japan 431-3192
Telephone +81-53-435-2312
E-mail natsumeo@hama-med.ac.jp
Affiliation Hamamatsu University School of Medicine
Scientific contact
Name Osamu Natsume
Address 1-20-1 Handayama,Higashi-ku,Hamamatsu,Shizuoka,Japan, Shizuoka Japan 431-3192
Telephone +81-53-435-2312
E-mail natsumeo@hama-med.ac.jp
Affiliation Hamamatsu University School of Medicine